IDO1 and neoplasm: Several interventions inhibiting IDO1 have been shown to decrease tumor growth and elicit an immune response in rodent tumor models (30–34) but targeting IDO1 as a standalone treatment has often failed to cause tumor eradication and to prevent disease progression altogether.